XNCR FY 2022 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$165M-40.2% YoY

Gross Profit

$165M100.0% margin

Operating Income

-$82M-50.1% margin

Net Income

-$55M-33.5% margin

EPS (Diluted)

$-0.93

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

-$19M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$846M

Total Liabilities

$119M

Stockholders' Equity

$727M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$165M	$275M	-40.2%
Gross Profit	$165M	$275M	-40.2%
Operating Income	-$82M	$44M	-288.4%
Net Income	-$55M	$83M	-166.8%